Cardiology GPSI Dr Matt Hughes outlines five key recent developments and their impact on GP practice including NICE hypertension guidance, new anticoagulants for stroke prevention, generic atorvastatin and new data on exercise referral.
Learning objectives
To give a GP focused update on five important developments in the area of cardiology:
- Latest NICE guidance on hypertension
- Doubts over the value of exercise referral
- Dabigatran and rivaroxaban as alternatives to warfarin in patients with atrial filbrillation
- The implications of generic versions of atorvastatin
- The four big unanswered questions on hypertension as identified by the European Society of Cardiology
This module is free for all registered members of Pulse Learning until 27 June 2012.
